Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology

Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis

Roger D. Soloway, W.H.J. Summerskill, Archie H. Baggenstoss et al. · Gastroenterology · 1972 · 726 citations

Medicine, Pathology, Pharmacotherapy +13

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

Gordon Cook, Rachel S. Mulligan, S. Sherlock · QJM · 1971 · 571 citations

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

Presentation of two bone marrow elements: The ‘tart cell’ and the ‘LE’ cell

Malcolm M. Hargraves, Helen Richmond, Randall P. Morton · 2001 · 569 citations

Life Sciences, Cell Biology, Pathology +14

CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS

I M Murray-Lyon, R. Stern, Roger Williams · The Lancet · 1973 · 475 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

W.H.J. Summerskill, M. G. Korman, Helmut V. Ammon et al. · Gut · 1975 · 356 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13